RMSYF OTC
Ramsay Health Care Limited
1W: +0.0%
1M: +23.8%
3M: +33.4%
YTD: +83.1%
1Y: +52.6%
3Y: +3.9%
5Y: -17.2%
$36.62
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$18.6B
+5.0% ▲
5Y CAGR: +7.6%
Gross Profit
$1.8B
-87.1% ▼
5Y CAGR: -28.3%
Operating Income
$1.0B
+16.4% ▲
5Y CAGR: -8.6%
Net Income
$329M
+1269.7% ▲
5Y CAGR: -6.0%
EPS (Diluted)
$1.36
+4494.6% ▲
5Y CAGR: -6.8%
EBITDA
$2.2B
+40.3% ▲
5Y CAGR: +13.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $13.1B | $15.0B | $16.6B | $17.7B | $18.6B |
| YoY Growth | +1.7% | +14.4% | +10.7% | +6.7% | +5.0% |
| Cost of Revenue | $3.1B | $3.3B | $3.7B | $4.0B | $16.8B |
| Gross Profit | $10.0B | $11.5B | $12.8B | $13.7B | $1.8B |
| Gross Margin | 76.2% | 77.0% | 77.6% | 77.3% | 9.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $8.3B | $9.4B | $10.3B | $11.0B | $756M |
| Operating Expenses | $9.7B | $11.0B | $12.0B | $12.8B | $756M |
| Operating Income | $1.4B | $1.6B | $833M | $870M | $1.0B |
| Operating Margin | 10.6% | 11.0% | 5.0% | 4.9% | 5.5% |
| Interest Expense | $147M | $261M | $613M | $335M | $608M |
| Income Before Tax | $523M | $527M | $385M | $102M | $513M |
| Tax Expense | $159M | $182M | $121M | $56M | $192M |
| Net Income | $274M | $298M | $889M | $24M | $329M |
| Net Margin | 2.1% | 2.0% | 5.4% | 0.1% | 1.8% |
| EPS (Diluted) | $1.09 | $1.16 | $1.11 | $0.03 | $1.36 |
| EBITDA | $1.6B | $1.8B | $1.8B | $1.6B | $2.2B |
| Shares Outstanding | 228M | 228M | 229M | 230M | 231M |